WVE · Insider trading · 13F holders · Congress trades
Wave Life Sciences, Inc. (WVE)
Who is buying and selling WVE: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 14
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $135K
- Congress trades, 12 months
- 0
WVE at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 4 WVE insiders filed 4 sales worth $135K on SEC Form 4, and no open-market purchases; 4 of the sales were pre-planned under Rule 10b5-1.
- 14 13F filers hold WVE among their 50 largest positions, worth $431.9M combined, including Peter Kolchinsky and Lee Ainslie. The biggest bets by portfolio weight are GSK plc (17.6%), Pfizer Inc (6.4%) and 683 Capital Management, LLC (2.8%). In their latest 13Fs, 2 managers opened a new position and 0 added to one.
- No member of Congress has disclosed a trade in WVE.
- WVE last closed at $3.63 on Oct 29, 2026.
WVE insider trading
Between Aug 1, 2026 and Oct 29, 2026, 4 WVE insiders filed 4 sales worth $135K on SEC Form 4, and no open-market purchases; 4 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Rawcliffe Adrian | Director | Sale10b5-1 | 12,700 | $5.29 | $67K | SEC |
| Aug 13, 2026 | Wagner Heidi L | Director | Sale10b5-1 | 7,000 | $6.01 | $42K | SEC |
| Aug 13, 2026 | Takanashi Ken | Director | Sale10b5-1 | 3,864 | $6.01 | $23K | SEC |
| Aug 13, 2026 | Tan Aik Na | Director | Sale10b5-1 | 432 | $6.01 | $3K | SEC |
Who owns WVE? Hedge funds and superinvestors
14 13F filers hold WVE among their 50 largest positions, worth $431.9M combined, including Peter Kolchinsky and Lee Ainslie. The biggest bets by portfolio weight are GSK plc (17.6%), Pfizer Inc (6.4%) and 683 Capital Management, LLC (2.8%). In their latest 13Fs, 2 managers opened a new position and 0 added to one.
Superinvestors holding WVE: Peter Kolchinsky 1.4% · Lee Ainslie 0.5%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Peter KolchinskyHedge fund | 1.4% | $156.7M | 26,975,505 | +0.0% shares | Q2 2026 |
| GSK plcCorporation | 17.6% | $106.0M | 18,245,691 | +0.0% shares | Q2 2026 |
| Lee AinslieSuperinvestor · Hedge fund | 0.5% | $59.7M | 10,278,115 | +1.1% shares | Q2 2026 |
| 683 Capital Management, LLCHedge fund | 2.8% | $28.8M | 4,950,000 | +1.0% shares | Q2 2026 |
| Readystate Asset Management LPHedge fund | 1.8% | $27.5M | 4,727,139 | — | Q2 2026 |
| M28 Capital Management LPHedge fund | 56.5% | $26.7M | 4,588,284 | +0.0% shares | Q2 2026 |
| Pfizer IncCorporation | 6.4% | $10.9M | 1,875,000 | +0.0% shares | Q2 2026 |
| SymBiosis Capital Partners, LLCHedge fund | 10.3% | $5.4M | 750,000 | New | Q1 2026 |
| Tang Capital Management LLCHedge fund | 0.2% | $3.5M | 600,000 | +0.0% shares | Q2 2026 |
| Ishara Investments LPHedge fund | 1.4% | $1.9M | 328,000 | New | Q2 2026 |
| Privium Fund Management B.V.Asset manager | 0.3% | $1.4M | 241,010 | +0.0% shares | Q2 2026 |
| Newtyn Management, LLCHedge fund | 0.2% | $1.2M | 215,000 | -28.3% shares | Q2 2026 |
| Sofinnova Investments, Inc.Hedge fund | 0.1% | $1.1M | 189,253 | — | Q2 2026 |
| Elmind Capital, LPHedge fund | 0.3% | $1.0M | 177,846 | +0.0% shares | Q2 2026 |
Each manager counts with its latest 13F (Q2 2026: 13, Q1 2026: 1). Screen WVE in the grand portfolio →
WVE stock trades by members of Congress
No member of Congress has disclosed a trade in WVE.
WVE questions and answers
Are insiders buying WVE stock?
Between Aug 1, 2026 and Oct 29, 2026, 4 WVE insiders filed 4 sales worth $135K on SEC Form 4, and no open-market purchases; 4 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own WVE?
14 13F filers hold WVE among their 50 largest positions, worth $431.9M combined, including Peter Kolchinsky and Lee Ainslie. The biggest bets by portfolio weight are GSK plc (17.6%), Pfizer Inc (6.4%) and 683 Capital Management, LLC (2.8%). In their latest 13Fs, 2 managers opened a new position and 0 added to one.
Has Congress traded WVE?
No member of Congress has disclosed a trade in WVE.
Who is the largest holder of WVE?
Among 13F filers, Peter Kolchinsky reports the largest WVE position, $156.7M (26,975,505 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is GSK plc's: 17.6% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.